) develop both right (RV) and left ventricular (LV) cardiomyopathy, manifested by LV dilatation and systolic dysfunction, as well as overexpression of genes conducive to heart failure. and WT mice was subjected to whole-genome gene microarray analysis. mice were consistently lower. mice associated with the spontaneous cardiomyopathy phenotype, involving both left and right ventricles, suggesting that loss of the VIP gene orchestrates a panoply of pathogenic genes which are detrimental to both left and right cardiac homeostasis
We aimed to understand the genetic control of cardiac remodeling using an isoproterenol-induced hear...
Numerous murine models of heart failure (HF) have been described, many of which develop progressive ...
SummaryWe previously reported a genetic analysis of heart failure traits in a population of inbred m...
RATIONALE: Vasoactive Intestinal Peptide (VIP), a pulmonary vasodilator and inhibitor of vascular sm...
Rationale: Vasoactive Intestinal Peptide (VIP), a pulmonary vasodilator and inhibitor of vascular sm...
<p>Genes alterations Related to Hypertrophic/Dilated Cardiomyopathy in VIP<sup>−/−</sup> mice compar...
Familial hypertrophic cardiomyopathy (FHC) is an autosomal dominant disease characterized by left ve...
Clinical presentation of congenital heart disease is heterogeneous, making identification of the di...
Clinical presentation of congenital heart disease is heterogeneous, making identification of the dis...
The ubiquitin-proteasome system (UPS) and the autophagy-lysosomal pathway (ALP) are the main proteol...
International audienceDilated cardiomyopathy (DCM) associates left ventricular (LV) dilatation and s...
Genetic factors are known to modulate cardiac susceptibility to ventricular hypertrophy and failure....
The genetics of heart failure is complex. In familial cases of cardiomyopathy, where mutations of la...
A traditional approach to investigate the genetic basis of complex diseases is to identify genes wit...
BACKGROUND - Familial hypertrophic cardiomyopathy (FHC) is characterized by genetic and clinical het...
We aimed to understand the genetic control of cardiac remodeling using an isoproterenol-induced hear...
Numerous murine models of heart failure (HF) have been described, many of which develop progressive ...
SummaryWe previously reported a genetic analysis of heart failure traits in a population of inbred m...
RATIONALE: Vasoactive Intestinal Peptide (VIP), a pulmonary vasodilator and inhibitor of vascular sm...
Rationale: Vasoactive Intestinal Peptide (VIP), a pulmonary vasodilator and inhibitor of vascular sm...
<p>Genes alterations Related to Hypertrophic/Dilated Cardiomyopathy in VIP<sup>−/−</sup> mice compar...
Familial hypertrophic cardiomyopathy (FHC) is an autosomal dominant disease characterized by left ve...
Clinical presentation of congenital heart disease is heterogeneous, making identification of the di...
Clinical presentation of congenital heart disease is heterogeneous, making identification of the dis...
The ubiquitin-proteasome system (UPS) and the autophagy-lysosomal pathway (ALP) are the main proteol...
International audienceDilated cardiomyopathy (DCM) associates left ventricular (LV) dilatation and s...
Genetic factors are known to modulate cardiac susceptibility to ventricular hypertrophy and failure....
The genetics of heart failure is complex. In familial cases of cardiomyopathy, where mutations of la...
A traditional approach to investigate the genetic basis of complex diseases is to identify genes wit...
BACKGROUND - Familial hypertrophic cardiomyopathy (FHC) is characterized by genetic and clinical het...
We aimed to understand the genetic control of cardiac remodeling using an isoproterenol-induced hear...
Numerous murine models of heart failure (HF) have been described, many of which develop progressive ...
SummaryWe previously reported a genetic analysis of heart failure traits in a population of inbred m...